<DOC>
	<DOCNO>NCT01193920</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity Group B Streptococcus vaccine one dose healthy non pregnant woman three different dos healthy pregnant woman .</brief_summary>
	<brief_title>Safety Immunogenicity Group B Streptococcus Vaccine Non Pregnant Pregnant Women 18-40 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Group 1 ( Non Pregnant Women ) : Healthy female 1840 year age inclusive . Group 2 ( Healthy Pregnant Women ) : Healthy pregnant woman 1840 yrs age ( 2835 week gestation ) Group 1 ( Non Pregnant Women ) : Pregnant nursing ; History severe allergy previous vaccine ; Known HIV positive Group 2 ( Healthy Pregnant Women ) : History severe allergy previous vaccine ; Known HIV positive</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Prevention group B streptococcus infection</keyword>
</DOC>